Psychedelics HAVN Life to make July appearance on renowned documentary series Biotechnology outfit set to receive attention on American TV this summer Rowan DunneJune 24, 2022
Psychedelics Nirvana Life Sciences boasts new patent for innovative psychedelic compound Company isolates 4-PO-Psilocin into biologically active salt with 99% purity ratio Rowan DunneJune 23, 2022
Coming soon PAREA: A new psychedelic-focused alliance of prominent companies with common goals Multi-organization psychedelic partnership set to launch on June 23 Rowan DunneJune 16, 2022
Business Numinus completes Novamind acquisition, upgrades leadership team Novamind's clinics in Utah and Arizona will continue to operate as their current brand until later this year Natalia Buendia CalvilloJune 14, 2022
Business Entheon Biomedical hands off DMT clinical study to Cybin Dimethyltryptamine continues to demonstrate tremendous therapeutic potential Rowan DunneJune 14, 2022
Canada Psilocybin and craft cannabis farmers to gather in B.C. Meeting for Vancouver Island growers and community leaders to be held on June 16. Rowan DunneJune 9, 2022
Business HAVN enters psilocybin mushroom supply agreement with Jamaican cannabis producer Green Stripe was one of the first cannabis companies to get established in Jamaica Natalia Buendia CalvilloJune 7, 2022
Psychedelics U.S. psychedelic drug market to reach $8.9B by 2029: DBMR report As rates of mental health disorders increase the demand for psychedelic treatments do too Rowan DunneJune 6, 2022
Business Optimi enters natural psilocybin supply agreement with Filament Health The mushrooms will be grown and distributed from Optimi's 20,000 square foot EU-GMP facility in Princeton Natalia Buendia CalvilloMay 31, 2022
Business Optimi Health enters psilocybin mushroom supply agreement with Halucenex Life Sciences The shrooms will be supplied to Halucenex in the form of whole, dried mushroom fruiting bodies Natalia Buendia CalvilloMay 27, 2022